TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive Also in this 8-page issue: Use cancer mortality, not 5-year survival, to track progress against cancer, researchers say. July 29, 2005
TCL Archive Also in this 8-page issue: Dana-Farber opens center for advanced cancer science. April 23, 2004
TCL Archive Job Discrimination Survey Completed, But NCI Still Trying To Interpret I; Payments May Be Held Up August 19, 1977
